Page last updated: 2024-08-24

capecitabine and Angiolymphoid Hyperplasia with Eosinophilia

capecitabine has been researched along with Angiolymphoid Hyperplasia with Eosinophilia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cubiró, X; Garcia-Muret, MP; Planas-Ciudad, S; Puig, L	1

Other Studies

1 other study(ies) available for capecitabine and Angiolymphoid Hyperplasia with Eosinophilia

Article	Year
Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine. JAMA dermatology, 2018, 01-01, Volume: 154, Issue:1 Topics: Administration, Topical; Aged; Angiolymphoid Hyperplasia with Eosinophilia; Antimetabolites, Antineoplastic; Capecitabine; Cohort Studies; Female; Humans; Male; Middle Aged; Neoplasms; Paronychia; Prognosis; Retrospective Studies; Timolol; Treatment Outcome	2018

Article

Year

Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine.

JAMA dermatology, 2018, 01-01, Volume: 154, Issue:1

Topics: Administration, Topical; Aged; Angiolymphoid Hyperplasia with Eosinophilia; Antimetabolites, Antineoplastic; Capecitabine; Cohort Studies; Female; Humans; Male; Middle Aged; Neoplasms; Paronychia; Prognosis; Retrospective Studies; Timolol; Treatment Outcome

2018